Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
160.95
+4.16 (2.65%)
At close: Dec 5, 2025, 4:00 PM EST
162.01
+1.06 (0.66%)
After-hours: Dec 5, 2025, 7:59 PM EST
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 252.5, with a low estimate of 205 and a high estimate of 300. The average target predicts an increase of 56.88% from the current stock price of 160.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $225 → $205 | Strong Buy | Maintains | $225 → $205 | +27.37% | Aug 26, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +86.39% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +39.79% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +86.39% | May 15, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $60 → $150 | Strong Buy | Maintains | $60 → $150 | -6.80% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
980.80M
from 479.95M
Increased by 104.36%
Revenue Next Year
1.02B
from 980.80M
Increased by 4.10%
EPS This Year
15.37
from 9.69
Increased by 58.59%
EPS Next Year
12.50
from 15.37
Decreased by -18.68%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.0B | 1.1B | |
| Avg | 980.8M | 1.0B | |
| Low | 912.8M | 973.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.3% | 8.8% | |
| Avg | 104.4% | 4.1% | |
| Low | 90.2% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 15.82 | 20.54 | |
| Avg | 15.37 | 12.50 | |
| Low | 14.77 | 4.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 63.3% | 33.6% | |
| Avg | 58.6% | -18.7% | |
| Low | 52.4% | -68.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.